A Phase 2 Study of AZD0530 in Patients With Metastatic or Locally Advanced Gastric Carcinoma.
Phase of Trial: Phase II
Latest Information Update: 25 Aug 2018
At a glance
- Drugs Saracatinib (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 11 Apr 2013 Actual end date changed from Jan 2013 to Mar 2010 as reported by ClinicalTrials.gov.
- 01 Jan 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.